BPC-157 + TB500 + Bacteriostatic Water Research Kit

Certificate of Analysis (COA): See Images 

The Complete Research Protocol: BPC-157, TB-500 & Solvent.

This research bundle provides the three essential components required for high-level regenerative study: 5mg of BPC-157, 5mg of TB-500, and 10ml of Bacteriostatic Water. By supplying these compounds in their pure, lyophilized states alongside the necessary solvent, researchers can ensure maximum stability and precise concentration control at the time of reconstitution.

IMPORTANT: Why We Do Not Sell "Pre-Blended" Vials
At Tide Labs, we prioritize chemical integrity over convenience. While other vendors may sell single vials containing both peptides mixed together, we refuse to do so. BPC-157 and TB-500 have different molecular weights, pH stability requirements, and degradation rates. Mixing them in a solution for long-term storage or during the lyophilization process often leads to the degradation of one or both peptides before they even reach the lab bench.
To understand the science behind why separate vials are the only professional choice, read our full analysis: Why Tide Labs Doesn't Mix BPC-157 & TB-500.

Area of Interest

Researchers have investigated the BPC-157 + TB-500 combination across several areas of preclinical and laboratory study. The inclusion of bacteriostatic water allows for immediate and sterile reconstitution for experimental application:

• Tissue Healing: Both peptides are explored for their roles in supporting tendon, ligament, and muscle recovery in injury models.
• Angiogenesis & Blood Flow: TB-500 has been studied for promoting new blood vessel growth, while BPC-157 has been linked with protective effects on vascular tissue.
• Anti-Inflammatory Potential: Evidence suggests both peptides may influence inflammatory pathways, making the concurrent study of these separate compounds highly relevant in chronic injury research.
• Synergistic Effects: By combining BPC-157’s focus on gut and connective tissue repair with TB-500’s angiogenic and cellular migration properties, researchers are exploring whether the protocol offers a broader range of regenerative potential.

This combination is regarded in research settings as a versatile and promising area of study within peptide science.

Technical Information

• Chemical Names: Pentadecapeptide BPC-157 & Thymosin Beta-4 Fragment (TB-500)
• Kit Contents: 1x BPC-157 (5mg), 1x TB-500 (5mg), 1x Bacteriostatic Water (10ml)
• Solvent Composition: Sterile Water with 0.9% Benzyl Alcohol (Bacteriostatic agent)
• Molecular Formula (BPC-157): C₆₂H₉₈N₁₆O₂₂
• Molecular Weight (BPC-157): 1419.53 g/mol
• Molecular Formula (TB-500): C₂₁₂H₃₅₀N₅₆O₇₈S
• Molecular Weight (TB-500): ~4963 g/mol (full Thymosin Beta-4 fragment equivalent)
• Peptide Classification: Synthetic peptides – BPC-157 derived from gastric protein, TB-500 derived from Thymosin Beta-4

Storage Guidelines

• Lyophilized peptides (powder) are stable at room temperature for short periods.
• For long-term storage of the powder vials, keep at −20°C or below.
• Bacteriostatic Water: Store at room temperature (15–25°C). Do not freeze.

• Once reconstituted (mixed), store peptide solutions at 2–8 °C. The Benzyl Alcohol in the solvent preserves sterility for up to 28 days after opening.

Solubility

Both peptides are fully soluble in the included Bacteriostatic Water. The 10ml volume allows for flexible concentration ratios depending on the specific requirements of the research protocol.

References

• Sikiric, P., Seiwerth, S., Grabarevic, Z., et al. (2001). “A new gastric juice peptide, BPC, heals both acute and chronic gastrointestinal lesions.” Journal of Physiology (Paris), 95(1-6), 79–92. https://doi.org/10.1016/S0928-4257(01)00011-5
• Philp, D., Badamchian, M., Scheremeta, B., et al. (2003). “Thymosin beta4 and angiogenesis: initiation of new blood vessel growth.” Annals of the New York Academy of Sciences, 1002, 168–177. https://doi.org/10.1196/annals.1283.018
• Malinda, K. M., Sidhu, G. S., Mani, H., et al. (1999). “Thymosin beta4 accelerates wound healing.” Journal of Investigative Dermatology, 113(3), 364–368. https://doi.org/10.1046/j.1523-1747.1999.00705.x
• Seiwerth, S., Rucman, R., Turkovic, B., et al. (2014). “Stable gastric pentadecapeptide BPC 157: novel mediator of Robert’s cytoprotection and adaptive cytoprotection.” Current Pharmaceutical Design, 20(7), 1126–1135. https://doi.org/10.2174/13816128113199990435

Certificate of Analysis (COA): See Images